In this online CME self-learning program:
Rheumatoid arthritis (RA) is a systemic autoimmune disorder in which joints, typically those in the hands and feet, become inflamed, swollen, painful, and stiff. Without appropriate treatment, the inflammation may become chronic and cause irreversible destruction of bone and cartilage in the affected joints as well as contribute to the development of clinically important co-morbid conditions with attendant morbidity and mortality. The National Arthritis Data Workgroup estimates that about 1.3 million U.S. adults (0.6% of the adult population) have RA. RA imposes a considerable disease burden. Patients with RA have substantially lower health-related quality of life (QOL) than the general population with lower overall scores for physical and mental health across all age groups. The RA disease burden also is associated with increased health care resource utilization. Notably, RA patients with low QOL are twice as likely to be hospitalized as RA patients with high QOL.
The revised 2010 ACR/European League Against Rheumatism (EULAR) Diagnostic Criteria for Rheumatoid Arthritis expanded the number of potential patients eligible for RA treatment. Moreover, guidelines governing the treatment of RA have been updated fairly recently. The literature suggests that practicing healthcare professionals are oftentimes unable to keep up with the steady publishing of literature and evolution of clinical practice, and awareness of professional guidelines is no exception. Recently published guidelines therefore also inherently suggest a gap in medical practice and justify the need for educational programming.
Agenda:
Rheumatologists and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in rheumatology; and any other healthcare professionals with an interest in or who clinically encounter patients with RA.
Commercial Support Disclosure: This program is supported by an educational grant from Mallinckdrodt.
Release Date: December 13, 2016 -- Expiration Date: December 13, 2018
Faculty: Yousaf Ali, MD, FACR
By the end of the session the participant will be able to:
ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Faculty Disclosure: Dr. Ali, MD, Associate Professor of Medicine Icahn School of Medicine at Mount Sinai, has no relevant financial disclosures.
Disclosures of Educational Planners: Charles Turck, PharmD has no relevent financial disclosures.
Commercial Support Disclosure: This program is supported by an educational grant from Mallinckdrodt.
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.
Rheumatoid Arthritis (RA): Optimizing Pharmacotherapeutic Management Strategies
Psoriasis: Best Practices, Barriers to Care, and Emerging Therapies in Medication Management
Rheumatoid Arthritis (RA) : Therapeutic Updates and Optimizing Treatment
Psoriatic Arthritis: Therapeutic Updates and Optimizing Treatment